125 related articles for article (PubMed ID: 8432918)
1. Quantitative and qualitative assessment of plasma von Willebrand factor in classic Kaposi's sarcoma.
Hodak E; Trattner A; David M; Kornbrot N; Modan B; Lurie H; Lawrie A; Harrison P; Sandbank M; Inbal A
J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):217-21. PubMed ID: 8432918
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous and plasma values of von Willebrand factor in AIDS: a marker of endothelial stimulation?
Janier M; Flageul B; Drouet L; Scrobohaci ML; Villette JM; Palangie A; Cottenot F
J Invest Dermatol; 1988 May; 90(5):703-7. PubMed ID: 3258899
[TBL] [Abstract][Full Text] [Related]
3. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
4. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma.
Hodak E; Hammel I; Feinmesser M; Zelinger A; Maron L; Sulkes J; David M
Am J Dermatopathol; 1999 Apr; 21(2):138-45. PubMed ID: 10218673
[TBL] [Abstract][Full Text] [Related]
7. Content and functional activity of von Willebrand factor in apheresis plasma.
Burnouf T; Caron C; Burkhardt T; Goudemand J
Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
[TBL] [Abstract][Full Text] [Related]
8. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients.
Uccini S; Sirianni MC; Vincenzi L; Topino S; Stoppacciaro A; Lesnoni La Parola I; Capuano M; Masini C; Cerimele D; Cella M; Lanzavecchia A; Allavena P; Mantovani A; Baroni CD; Ruco LP
Am J Pathol; 1997 Mar; 150(3):929-38. PubMed ID: 9060831
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma.
Marfia G; Navone SE; Fanizzi C; Tabano S; Pesenti C; Abdel Hadi L; Franzini A; Caroli M; Miozzo M; Riboni L; Rampini P; Campanella R
Cancer Med; 2016 Aug; 5(8):1783-90. PubMed ID: 27236861
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor antigen levels in Kaposi's sarcoma.
Penneys NS; Kott-Blumenkranz R; Civantos F; Kent J
J Am Acad Dermatol; 1986 Dec; 15(6):1214-7. PubMed ID: 3100582
[TBL] [Abstract][Full Text] [Related]
13. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
[TBL] [Abstract][Full Text] [Related]
14. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
15. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.
Philippe A; Chocron R; Gendron N; Bory O; Beauvais A; Peron N; Khider L; Guerin CL; Goudot G; Levasseur F; Peronino C; Duchemin J; Brichet J; Sourdeau E; Desvard F; Bertil S; Pene F; Cheurfa C; Szwebel TA; Planquette B; Rivet N; Jourdi G; Hauw-Berlemont C; Hermann B; Gaussem P; Mirault T; Terrier B; Sanchez O; Diehl JL; Fontenay M; Smadja DM
Angiogenesis; 2021 Aug; 24(3):505-517. PubMed ID: 33449299
[TBL] [Abstract][Full Text] [Related]
16. Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura.
Casonato A; Pontara E; Bertomoro A; Ossi E; Vincenti M; Girolami A; Borsatti A; Bertaglia G
Am J Hematol; 1996 Jan; 51(1):7-11. PubMed ID: 8571941
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
Dictor M; Rambech E; Way D; Witte M; Bendsöe N
Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells.
Uccini S; Ruco LP; Monardo F; Stoppacciaro A; Dejana E; La Parola IL; Cerimele D; Baroni CD
J Pathol; 1994 May; 173(1):23-31. PubMed ID: 7523640
[TBL] [Abstract][Full Text] [Related]
19. Multimers of von Willebrand antigen in therapeutic factor VIII concentrates.
Vukovich TC
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):831-40. PubMed ID: 2436998
[TBL] [Abstract][Full Text] [Related]
20. Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms.
Favaloro EJ; Facey D; Grispo L
Am J Clin Pathol; 1995 Sep; 104(3):264-71. PubMed ID: 7677113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
